908 results on '"Liu, Kangdong"'
Search Results
2. DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability
3. Sliding-attention transformer neural architecture for predicting T cell receptor–antigen–human leucocyte antigen binding
4. Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo
5. Elongation factor 2 in cancer: a promising therapeutic target in protein translation
6. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
7. Mutations found in cancer patients compromise DNA binding of the winged helix protein STK19
8. Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma
9. Protein translation: biological processes and therapeutic strategies for human diseases
10. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
11. CHI-KAT8i5 suppresses ESCC tumor growth by inhibiting KAT8-mediated c-Myc stability
12. Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery
13. Insights into the distinct membrane targeting mechanisms of WDR91 family proteins
14. Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC
15. Design, synthesis, and antiproliferative activity evaluation of novel α-mangostin derivatives by ROS/MAPK signaling pathway
16. Advancements in therapeutic peptides: Shaping the future of cancer treatment
17. Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells via HuR-mediated mRNA stabilization
18. Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models
19. Selective inhibition of c-Met signaling pathways with a bispecific DNA nanoconnector for the targeted therapy of cancer
20. Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4′-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression
21. Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis
22. PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription
23. Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin
24. Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3
25. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine
26. Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy
27. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3
28. CAFrgDB: a database for cancer-associated fibroblasts related genes and their functions in cancer
29. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma
30. Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
31. Target discovery of bioactive natural products with native-compound-coupled CNBr-activated Sepharose 4B beads (NCCB): Applications, mechanisms and outlooks
32. Recent advances of antitumor leading compound Erianin: Mechanisms of action and structural modification
33. Native-compound-Coupled Affinity Matrix (NCAM) in target identification and validation of bioactive compounds: Application, mechanism and outlooks
34. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
35. Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer
36. Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
37. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
38. Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
39. Integrins in cancer: Emerging mechanisms and therapeutic opportunities
40. DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β
41. OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer
42. NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway
43. A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC
44. Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
45. Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
46. MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma
47. Ubiquitination of ADRα1d/SerpinA1 complex stimulates hypoxia to induce gastric tumorigenesis with a combination of Helicobacter pylori and chronic stress through IL-1α
48. Inflammation in cancer: therapeutic opportunities from new insights.
49. Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials.
50. 20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.